Inhibition of Rac controls NPM-ALK-dependent lymphoma development and dissemination.

Abstract : Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) is a tyrosine kinase oncogene responsible for the pathogenesis of the majority of human ALK-positive lymphomas. We recently reported that it activated the Rac1 GTPase in anaplastic large-cell lymphoma (ALCL), leading to Rac-dependent formation of active invadopodia required for invasiveness. Herein, we went further into the study of this pathway and used the inhibitor of Rac, NSC23766, to validate its potential as a molecular target in ALCL in vitro and in vivo in a xenograft model and in a conditional model of NPM-ALK transgenic mice. Our data demonstrate that Rac regulates important effectors of NPM-ALK-induced transformation such as Erk1/2, p38 and Akt. Moreover, inhibition of Rac signaling abrogates NPM-ALK-elicited disease progression and metastasis in mice, highlighting the potential of small GTPases and their regulators as additional therapic targets in lymphomas.
Type de document :
Article dans une revue
Blood Cancer Journal, Nature Publishing Group, 2011, 1 (6), pp.e21. 〈10.1038/bcj.2011.19〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00726858
Contributeur : Marie Francoise Simon <>
Soumis le : vendredi 31 août 2012 - 13:58:01
Dernière modification le : jeudi 9 novembre 2017 - 09:38:02

Lien texte intégral

Identifiants

Collections

Citation

A. Colomba, Sylvie Giuriato, Emilie Dejean, K. Thornber, Georges Delsol, et al.. Inhibition of Rac controls NPM-ALK-dependent lymphoma development and dissemination.. Blood Cancer Journal, Nature Publishing Group, 2011, 1 (6), pp.e21. 〈10.1038/bcj.2011.19〉. 〈inserm-00726858〉

Partager

Métriques

Consultations de la notice

95